Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

Abstract

In recent years, natural products, which originate from plants, animals, and fungi, together with their bioactive compounds have been intensively explored and studied for their therapeutic potentials for various diseases such as cardiovascular, diabetes, hypertension, reproductive, cancer, and neurodegenerative diseases. Neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis are characterized by the progressive dysfunction and loss of neuronal structure and function that resulted in the neuronal cell death. Since the multifactorial pathological mechanisms are associated with neurodegeneration, targeting multiple mechanisms of actions and neuroprotection approach, which involves preventing cell death and restoring the function to damaged neurons, could be promising strategies for the prevention and therapeutic of neurodegenerative diseases. Natural products have emerged as potential neuroprotective agents for the treatment of neurodegenerative diseases. This review focused on the therapeutic potential of natural products and their bioactive compounds to exert a neuroprotective effect on the pathologies of neurodegenerative diseases.

References 304

1. 1.

   Yildiz-Unal A., Korulu S., Karabay A. Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatric Disease and Treatment. 2015;11:297-310.

   Not in our library10.2147/ndt.s78226

2. 2.

   Przedborski S., Vila M., Jackson-Lewis V. Series introduction: neurodegeneration: what is it and where are we? Journal of Clinical Investigation. 2003;111(1):3-10.

   Not in our library10.1172/jci200317522

3. 3.

   Gao H.-M., Hong J.-S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends in Immunology. 2008;29(8):357-365.

   Not in our library10.1016/j.it.2008.05.002

4. 4.

   Allan S. M., Rothwell N. J. Cytokines and acute neurodegeneration. Nature Reviews Neuroscience. 2001;2(10):734-744.

   Not in our library10.1038/35094583

5. 5.

   Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P. L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. European Journal of Pharmacology. 2013;698(1–3):6-18.

   Not in our library10.1016/j.ejphar.2012.10.032

6. 6.

   Jellinger K. A. Basic mechanisms of neurodegeneration: a critical update. Journal of Cellular and Molecular Medicine. 2010;14(3):457-487.

   Not in our library10.1111/j.1582-4934.2010.01010.x

7. 7.

   Salińska E., Danysz W., Łazarewicz J. W. The role of excitotoxicity in neurodegeneration. Folia Neuropathologica. 2005;43(4):322-339.

   Not in our library

8. 8.

   Gorman A. M. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. Journal of Cellular and Molecular Medicine. 2008;12(6a):2263-2280.

   Not in our library10.1111/j.1582-4934.2008.00402.x

9. 9.
   Oxidative Stress: A Key Modulator in Neurodegenerative Diseases · 2019

   No notice
10. 10.
    Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View · 2019

    No notice
11. 11.
    Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications · 2017

    No notice
12. 12.

    Chitnis T., Weiner H. L. CNS inflammation and neurodegeneration. Journal of Clinical Investigation. 2017;127(10):3577-3587.

    Not in our library10.1172/jci90609

13. 13.

    Chen W.-W., Zhang X., Huang W.-J. Role of neuroinflammation in neurodegenerative diseases (review). Molecular Medicine Reports. 2016;13(4):3391-3396.

    Not in our library10.3892/mmr.2016.4948

14. 14.

    Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918-934.

    Not in our library10.1016/j.cell.2010.02.016

15. 15.

    Fan J., Dawson T. M., Dawson V. L., Beart P., Robinson M., Rattray M., et al. Cell death mechanisms of neurodegeneration. Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets. 2017;403-425.

    Not in our library

16. 16.

    Mattson M. P., Schapira A., Wszolek Z., Dawson T. M., et al. Excitotoxicity. Neurodegeneration. 2017.

    Not in our library

17. 17.

    Jellinger K. A. General aspects of neurodegeneration. Advances in Research on Neurodegeneration. 2003;(65):101-144.

    Not in our library10.1007/978-3-7091-0643-3_7

18. 18.

    Apostolova L. G. Alzheimer disease. Continuum: Lifelong Learning in Neurology. 2016;22(2):419-434.

    Not in our library10.1212/con.0000000000000307

19. 19.

    Mhyre T. R., Boyd J. T., Hamill R. W., Maguire-Zeiss K. A. Parkinson’s disease. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. 2012;65:389-455.

    Not in our library10.1007/978-94-007-5416-4_16

20. 20.
    Amyotrophic lateral sclerosis · 2009

    No notice
21. 21.

    Hsu Y.-T., Chang Y.-G., Chern Y. Insights into GABA A ergic system alteration in Huntington’s disease. Open Biology. 2018;8(12):p. 180165.

    Not in our library10.1098/rsob.180165

22. 22.

    Macdonald M. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72(6):971-983.

    Not in our library10.1016/0092-8674(93)90585-e

23. 23.
    Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease · 2018

    No notice
24. 24.

    Leszek J., Barreto G. E., G|siorowski K., Koutsouraki E., Ávila-Rodrigues M., Aliev G. Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system. CNS & Neurological Disorders-Drug Targets. 2016;15(3):329-336.

    Not in our library10.2174/1871527315666160202125914

25. 25.

    Fakhoury M. Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases. Neurodegenerative Diseases. 2015;15(2):63-69.

    Not in our library10.1159/000369933

26. 26.

    Estrada Sánchez A. M., Mejía-Toiber J., Massieu L. Excitotoxic neuronal death and the pathogenesis of huntington’s disease. Archives of Medical Research. 2008;39(3):265-276.

    Not in our library10.1016/j.arcmed.2007.11.011

27. 27.

    Doble A. The role of excitotoxicity in neurodegenerative disease. Pharmacology & Therapeutics. 1999;81(3):163-221.

    Not in our library10.1016/s0163-7258(98)00042-4

28. 28.

    Dong X.-x., Wang Y., Qin Z.-h. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacologica Sinica. 2009;30(4):379-387.

    Not in our library10.1038/aps.2009.24

29. 29.

    Wang Q., Yu S., Simonyi A., Sun G. Y., Sun A. Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Molecular Neurobiology. 2005;31(1–3):3-16.

    Not in our library10.1385/mn:31:1-3:003

30. 30.

    Zheng X. Y., Zhang H. L., Luo Q., Zhu J. Kainic acid-induced neurodegenerative model: potentials and limitations. Journal of Biomedicine and Biotechnology. 2011;2011:10.

    Not in our library10.1155/2011/457079

31. 31.

    Ullah I., Park H. Y., Kim M. O. Anthocyanins protect against kainic acid-induced excitotoxicity and apoptosis via ROS-activated AMPK pathway in hippocampal neurons. CNS Neuroscience & Therapeutics. 2014;20(4):327-338.

    Not in our library10.1111/cns.12218

32. 32.

    Okouchi M., Ekshyyan O., Maracine M., Aw T. Y. Neuronal apoptosis in neurodegeneration. Antioxidants & Redox Signaling. 2007;9(8):1059-1096.

    Not in our library10.1089/ars.2007.1511

33. 33.
    Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action · 2018

    No notice
34. 34.

    Porcza L., Simms C., Chopra M. Honey and cancer: current status and future directions. Diseases. 2016;4(4):p. 30.

    Not in our library10.3390/diseases4040030

35. 35.

    Bogdanov S., Jurendic T., Sieber R., Gallmann P. Honey for nutrition and health: a review. Journal of the American College of Nutrition. 2008;27(6):677-689.

    Not in our library10.1080/07315724.2008.10719745

36. 36.

    Erejuwa O. O., Sulaiman S. A., Wahab M. S. A. Honey-a novel antidiabetic agent. International Journal of Biological Sciences. 2012;8(6):913-934.

    Not in our library10.7150/ijbs.3697

37. 37.

    Bobis O., Dezmirean D. S., Moise A. R. Honey and diabetes: the importance of natural simple sugars in diet for preventing and treating different type of diabetes. Oxidative Medicine and Cellular Longevity. 2018;2018:12.

    Not in our library10.1155/2018/4757893

38. 38.

    Samarghandian S., Farkhondeh T., Samini F. Honey and health: a review of recent clinical research. Pharmacognosy Research. 2017;9(2):121-127.

    Not in our library10.4103/0974-8490.204647

39. 39.

    Deng J., Liu R., Lu Q., et al. Biochemical properties, antibacterial and cellular antioxidant activities of buckwheat honey in comparison to manuka honey. Food Chemistry. 2018;252:243-249.

    Not in our library10.1016/j.foodchem.2018.01.115

40. 40.

    Aumeeruddy M. Z., Aumeeruddy-Elalfi Z., Neetoo H., et al. Pharmacological activities, chemical profile, and physicochemical properties of raw and commercial honey. Biocatalysis and Agricultural Biotechnology. 2019;18.

    Not in our library10.1016/j.bcab.2019.01.043

Cited by papers we hold 2

• The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms · 2023
  No notice
• Neuroprotective Natural Products for Alzheimer’s Disease · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.